Recent Quarter Total Invested
$1.87 M
Recent Quarter Institutional Ownership Percentage
10.85%
Total Invested of Last Quarter
$303,946
Ownership Percentage of Last Quarter
1.09%
NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 1.58 M | $1.77 M | 100.00% | 10.28% |
| MEITAV INVESTMENT HOUSE LTD | 07/29/2024 | 40,000 | $44,800 | -20.00% | 0.26% |
| XTX TOPCO LTD | 08/12/2024 | 32,650 | $36,568 | 100.00% | 0.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 11,963 | $13,398 | 0.00% | 0.08% |
| MORGAN STANLEY | 08/14/2024 | 1,500 | $1,680 | 0.00% | 0.01% |
| CWM, LLC | 07/10/2024 | 1,000 | $1,000 | 0.00% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 54 | $60 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WOODLINE PARTNERS LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
NeuroSense Therapeutics Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NRSN shares?
During the previous two years, 10 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.58 M
MEITAV INVESTMENT HOUSE LTD: 40,000
XTX Topco Ltd: 32,650
GEODE CAPITAL MANAGEMENT, LLC: 11,963
MORGAN STANLEY: 1,500
CWM, LLC: 1,000
-
What percentage of NeuroSense Therapeutics Ltd. stock is owned by institutional investors?
10.85% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at NRSN ?
Institutional investors have bought a total of 1.67 M shares in the last 24 months. This purchase volume represents approximately $2.04 M in transactions.